The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SAR SAREUM HOLDINGS PLC ORD 0.025P




Time/Date Code Headline Source Impact
07:00 19-Oct-2017 SAR Final Results RNS -15.88% Down
12:00 09-Oct-2017 SAR Sierra Oncology host KOL Meeting on 12 Oct in NY RNS +8.16% Up
12:00 18-Sep-2017 SAR Sierra Oncology to host call on Chk1 inhibitor RNS +2.98% Up
07:00 22-Aug-2017 SAR Pre-Close Trading Statement RNS +6.29% Up
07:00 19-Jun-2017 SAR Sareum to Present at the ICCS 2017 RNS +2.29% Up
12:13 05-Jun-2017 SAR Chk1 Clinical Trials Update RNS +1.26% Up
07:00 31-May-2017 SAR Sierra Oncology Granted US and EU Patents RNS +3.43% Up
07:00 25-May-2017 SAR Sierra Oncology to Present at ASCO Annual Meeting RNS -0.98% Down
07:00 09-May-2017 SAR Sareum to Present at BioTrinity 2017 RNS +5.68% Up
07:00 09-Mar-2017 SAR Director Shareholding RNS -2.07% Down
07:00 20-Feb-2017 SAR Half-year Results RNS -7.08% Down
07:00 09-Feb-2017 SAR Notice of Interim Results RNS +2.42% Up
12:05 09-Jan-2017 SAR Milestone Payment from Chk1 Licence Agreement RNS +9.31% Up
09:47 22-Dec-2016 SAR Result of General Meeting RNS -3.23% Down
11:38 15-Dec-2016 SAR Result of AGM RNS -3.61% Down
07:00 06-Dec-2016 SAR Directors' Remuneration & General Meeting RNS -5.00% Down
07:00 29-Nov-2016 SAR Sareum to Present at AACR-NCI-EORTC Conference RNS -5.33% Down
07:00 21-Nov-2016 SAR Notice of AGM RNS -1.74% Down
07:00 02-Nov-2016 SAR Final Results RNS -8.74% Down
07:00 24-Oct-2016 SAR Successful Outcome from TYK2 Feasibility Study RNS -5.38% Down


Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.





Company Information
Updated Monthly
Company address Unit 2a, Langford Arch, London Road, Pampisford, Cambridge, CB22 3FX, United Kingdom
Company website http://www.sareum.co.uk
Market cap(in millions)* £ 23.15
Listing/Admission to trading 11 Oct 2004
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
24-Oct-17
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIM
MiFID Status MTF
Exchange market size 300,000
SEDOL B02RFS1
ISIN number GB00B02RFS12



SAREUM share news analysis (SAR)